Cardinal Health (CAH) is a Great Momentum Stock: Should You Buy?

Cardinal Health (CAH) is identified as a strong momentum stock, boasting a Zacks Momentum Style Score of 'A' and a Zacks Rank #2 (Buy), indicators historically associated with market outperformance. The prescription drug distributor has significantly outperformed broader markets and its industry, with shares surging 71.85% over the past year against the S&P 500's 14.92% gain. This robust price action is complemented by positive earnings estimate revisions, as the current year's consensus estimate recently climbed from $7.99 to $8.18, reinforcing its favorable outlook.

Analysis

Cardinal Health (CAH) demonstrates compelling characteristics of a momentum stock, supported by both significant price appreciation and positive fundamental revisions. The stock has substantially outperformed, with a 71.85% gain over the past year compared to the S&P 500's 14.92% increase, and a 33.67% rise in the last quarter. This outperformance extends to its sector, with CAH's 8.21% monthly gain far exceeding the Medical - Dental Supplies industry's 1.01% rise. Crucially, this price momentum is underpinned by a strengthening earnings outlook. Over the past 60 days, eight analysts have revised full-year earnings estimates upward with no downward revisions, pushing the consensus estimate from $7.99 to $8.18. This positive revision trend is mirrored for the next fiscal year, reinforcing analyst confidence. The combination of these factors culminates in a Zacks Rank of #2 (Buy) and a Momentum Style Score of 'A', indicators that historically correlate with near-term market outperformance.

Key Decisions for Investors

• Given the stock's powerful price momentum and significant outperformance against its industry and the S&P 500, investors following a momentum strategy should consider CAH a strong candidate.
• The unanimous upward revisions in earnings estimates for both the current and next fiscal year provide fundamental validation for the rally, suggesting that investors with existing positions could consider holding or adding to them.
• It is crucial to monitor for any potential slowdown or reversal in earnings estimate revisions, as this positive trend is a core pillar of the current bullish thesis and a change could signal a turning point for the stock's trajectory.